Home > National Drug Code (NDC) > CLINIQUE CX

CLINIQUE CX - 49527-953-01 - (OCTINOXATE, OCTISALATE, ZINC OXIDE,TITANIUM DIOXIDE)

Alphabetical Index


Drug Information of CLINIQUE CX

Product NDC: 49527-953
Proprietary Name: CLINIQUE CX
Non Proprietary Name: OCTINOXATE, OCTISALATE, ZINC OXIDE,TITANIUM DIOXIDE
Active Ingredient(s): 7.5; 5; 1.7; 4.6    mL/100mL; mL/100mL; mL/100mL; mL/100mL & nbsp;   OCTINOXATE, OCTISALATE, ZINC OXIDE,TITANIUM DIOXIDE
Administration Route(s): TOPICAL
Dosage Form(s): CREAM
Coding System: National Drug Codes(NDC)

Labeler Information of CLINIQUE CX

Product NDC: 49527-953
Labeler Name: CLINIQUE LABORATORIES INC
Product Type: HUMAN OTC DRUG
FDA Application Number: part352
Marketing Category: OTC MONOGRAPH NOT FINAL
Start Marketing Date: 20050501

Package Information of CLINIQUE CX

Package NDC: 49527-953-01
Package Description: 1 TUBE in 1 CARTON (49527-953-01) > 50 mL in 1 TUBE (49527-953-02)

NDC Information of CLINIQUE CX

NDC Code 49527-953-01
Proprietary Name CLINIQUE CX
Package Description 1 TUBE in 1 CARTON (49527-953-01) > 50 mL in 1 TUBE (49527-953-02)
Product NDC 49527-953
Product Type Name HUMAN OTC DRUG
Non Proprietary Name OCTINOXATE, OCTISALATE, ZINC OXIDE,TITANIUM DIOXIDE
Dosage Form Name CREAM
Route Name TOPICAL
Start Marketing Date 20050501
Marketing Category Name OTC MONOGRAPH NOT FINAL
Labeler Name CLINIQUE LABORATORIES INC
Substance Name OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE
Strength Number 7.5; 5; 1.7; 4.6
Strength Unit mL/100mL; mL/100mL; mL/100mL; mL/100mL
Pharmaceutical Classes

Complete Information of CLINIQUE CX


General Information